If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Barbara Valeri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram

Maurichi, A., Miceli, R., Eriksson, H., Newton-Bishop, J., Nsengimana, J., Chan, M., Hayes, A. J., Heelan, K., Adams, D., Patuzzo, R., Barretta, F., Gallino, G., Harwood, C., Bergamaschi, D., Bennett, D., Lasithiotakis, K., Ghiorzo, P., Dalmasso, B., Manganoni, A., Consoli, F. & 28 others, Mattavelli, I., Barbieri, C., Leva, A., Cortinovis, U., Espeli, V., Mangas, C., Quaglino, P., Ribero, S., Broganelli, P., Pellacani, G., Longo, C., Del Forno, C., Borgognoni, L., Sestini, S., Pimpinelli, N., Fortunato, S., Chiarugi, A., Nardini, P., Morittu, E., Florita, A., Cossa, M., Valeri, B., Milione, M., Pruneri, G., Zoras, O., Anichini, A., Mortarini, R. & Santinami, M., May 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 14, p. 1591-1601 11 p.

Research output: Contribution to journalArticle

  • MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

    IMI Study Group, GEM Study Group & M-SKIP Study Group, May 1 2019, In : The Lancet Child and Adolescent Health. 3, 5, p. 332-342 11 p.

    Research output: Contribution to journalArticle

  • MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort: The Lancet Child and Adolescent Health

    IMI Study Group, the GEM Study Group, and the M-SKIP Study Group, 2019, In : Lancet Child Adolesc. Health. 3, 5, p. 332-342 11 p.

    Research output: Contribution to journalArticle

    The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors

    Intergroup, I. M., Massi, D., Rulli, E., Cossa, M., Valeri, B., Rodolfo, M., Merelli, B., De Logu, F., Nassini, R., Del Vecchio, M., Di Guardo, L., De Penni, R., Guida, M., Sileni, V. C., Di Giacomo, A. M., Tucci, M., Occelli, M., Portelli, F., Vallacchi, V., Consoli, F. & 9 others, Quaglino, P., Queirolo, P., Baroni, G., Carnevale-Schianca, F., Cattaneo, L., Minisini, A., Palmieri, G., Rivoltini, L. & Mandalà, M., Nov 15 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, p. 1-13 13 p., 308.

    Research output: Contribution to journalArticle